Benitec Biopharma Inc. (BNTC)

NASDAQ: BNTC · Real-Time Price · USD

11.07

+0.02 (0.18%)

At close: Sep 16, 2026, 4:00 PM EDT

11.04

-0.03 (-0.27%)

After-hours: Sep 16, 2026, 4:10 PM EDT

Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	179.97	97.74	50.87	2.48	4.06
Cash & Short-Term Investments	179.97	97.74	50.87	2.48	4.06
Cash Growth	84.13%	92.16%	1953.53%	-39.02%	-79.45%
Accounts Receivable	-	-	-	0.06	0
Other Receivables	0	0.03	0.23	-	-
Receivables	0	0.03	0.23	0.06	0
Prepaid Expenses	1.6	0.63	0.52	1.18	0.74
Restricted Cash	0.11	0.11	0.06	0.01	0.01
Total Current Assets	181.69	98.52	51.67	3.73	4.82
Property, Plant & Equipment	0.87	0.99	0.45	0.61	0.99
Other Long-Term Assets	0.07	0.08	0.09	0.12	0.16
Total Assets	182.62	99.59	52.21	4.46	5.97

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	0.91	0.2	1.35	1.14	0.42
Accrued Expenses	0.66	0.52	0.65	0.74	0.7
Current Portion of Leases	0.5	0.35	0.28	0.28	0.25
Other Current Liabilities	3.27	0.72	2.64	1.82	1.16
Total Current Liabilities	5.34	1.8	4.92	3.98	2.53
Long-Term Leases	0.27	0.5	-	0.28	0.56
Pension & Post-Retirement Benefits	-	-	0.04	-	-
Total Liabilities	5.61	2.3	4.96	4.26	3.09

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	0	0	0	-	-
Additional Paid-In Capital	451.7	326.31	238.4	168.92	152.45
Retained Earnings	-273.72	-228.18	-190.26	-167.89	-148.33
Comprehensive Income & Other	-0.96	-0.84	-0.89	-0.83	-1.25
Shareholders' Equity	177.01	97.3	47.25	0.2	2.88
Total Liabilities & Equity	182.62	99.59	52.21	4.46	5.97

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	0.76	0.85	0.28	0.56	0.81
Net Cash (Debt)	179.21	96.9	50.58	1.92	3.25
Net Cash Growth	84.95%	91.56%	2537.23%	-41.00%	-83.38%
Net Cash Per Share	3.85	2.68	2.75	1.38	6.76
Filing Date Shares Outstanding	34.88	26.25	10.56	2.55	0.48
Total Common Shares Outstanding	34.42	26.25	10.09	1.65	0.48
Working Capital	176.34	96.72	46.75	-0.25	2.29
Book Value Per Share	5.14	3.71	4.68	0.12	6.00
Tangible Book Value	177.01	97.3	47.25	0.2	2.88
Tangible Book Value Per Share	5.14	3.71	4.68	0.12	6.00
Machinery	1.41	1.57	1.55	1.38	1.37
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02

SEC Filings: 10-K · 10-Q